Renaissance Technologies’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
1,529,553
+703,512
| +85% | +$816K | ﹤0.01% | 2187 |
|
|
2025
Q1 | $1.31M | Buy |
826,041
+286,696
| +53% | +$456K | ﹤0.01% | 2238 |
|
|
2024
Q4 | $1.63M | Sell |
539,345
-17,599
| -3% | -$53.3K | ﹤0.01% | 2179 |
|
|
2024
Q3 | $2.05M | Sell |
556,944
-104,738
| -16% | -$385K | ﹤0.01% | 2002 |
|
|
2024
Q2 | $2.71M | Buy |
661,682
+399,745
| +153% | +$1.63M | ﹤0.01% | 1685 |
|
|
2024
Q1 | $4.13M | Sell |
261,937
-47,340
| -15% | -$746K | 0.01% | 1535 |
|
|
2023
Q4 | $4.69M | Buy |
309,277
+23,840
| +8% | +$361K | 0.01% | 1392 |
|
|
2023
Q3 | $5.73M | Buy |
285,437
+75,000
| +36% | +$1.5M | 0.01% | 1225 |
|
|
2023
Q2 | $5.94M | Buy |
210,437
+177,700
| +543% | +$5.01M | 0.01% | 1332 |
|
|
2023
Q1 | $563K | Buy |
+32,737
| New | +$563K | ﹤0.01% | 2819 |
|
|
2022
Q2 | – | Sell |
-109,337
| Closed | -$5.05M | – | 4630 |
|
|
2022
Q1 | $5.05M | Buy |
+109,337
| New | +$5.05M | 0.01% | 1585 |
|
|
2021
Q4 | – | Sell |
-31,337
| Closed | -$2.09M | – | 4277 |
|
|
2021
Q3 | $2.09M | Buy |
+31,337
| New | +$2.09M | ﹤0.01% | 2052 |
|
|
2021
Q1 | – | Sell |
-6,397
| Closed | -$332K | – | 3774 |
|
|
2020
Q4 | $332K | Buy |
+6,397
| New | +$332K | ﹤0.01% | 2995 |
|